Eric Jia-Sobota, Founder, Author at EverGlade Consulting - Page 4 of 12

Eric Jia-Sobota, Founder

Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Practice and the Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others.

Eric Jia-Sobota, Co-Founder
Viral pathogen coronavirus

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats

Leave a Comment / All Posts, JPEO, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Prototype Proposals (RPP-25-06) under the Medical CBRN Defense Consortium (MCDC) under OTA W15QKN-16-9-1002. This new initiative, Operationalizing Novel Technologies for Advanced Rapid Generation of Effective Medical Countermeasures (ONTARGET), is looking […]

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats Read More »

3d rendered image of highly pathogenic avian influenza

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA), has issued a new Request for Prototype Proposals (RPP) through the Medical CBRN Defense Consortium (MCDC). “Increased Micro Sampling to Monitor Immunological Response” (IMMIR) seeks to improve our ability to monitor immune responses to vaccination, which is critical for accelerating vaccine

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP Read More »

digital rendering of antigens

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA), has released a new Request for Prototype Proposals (RPP-25-07) under the Medical CBRN Defense Consortium (MCDC). This Request for Project Proposals, titled “Defined Rapid Antigen Identification and Immunogenic Characterization” (DRAIIC), aims to increase protection against infectious

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP Read More »

Medicine production on conveyor belt

IBMSC RISE OTA Consortium RFI

Leave a Comment / All Posts, Life Sciences / By

Request for Information – IBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium In June 2025, the U.S. Department of Health and Human Services (HHS) issued a Request for Information (RFI) through the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC). This RFI invites feedback from

IBMSC RISE OTA Consortium RFI Read More »

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

Leave a Comment / DARPA, Emerging Technologies / By

Special Topic: Ag x BTO To defend against threats to America’s agricultural infrastructure, the Defense Advanced Research Projects Agency (DARPA) has launched a new Special Topic Area (STA) through its Biological Technologies Office (BTO). Known as Ag x BTO, this initiative seeks to catalyze innovative approaches to defending the U.S. agricultural system from chemical, biological,

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations Read More »

Vaccine Research

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA

Leave a Comment / BARDA, Life Sciences / By

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA BAA-23-100-SOL-00004 – Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) In response to today’s evolving public health landscape, the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS) within the Administration for Strategic

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA Read More »

Superconductor microchip with blue overlay

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Broad Agency Announcement Defense Sciences Office (DSO) Office-wide BAA Defense Sciences Office HR001125S0013 Pioneering the Next Generation of Defense Research On June 3, 2025, the Defense Advanced Research Projects Agency (DARPA), through its Defense Sciences Office (DSO), announced an open solicitation under Broad Agency Announcement (BAA) HR001125S0013. This office-wide BAA serves as a mechanism for

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA Read More »

Rapid Response Test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness

Leave a Comment / All Posts, BARDA, Life Sciences / By

In a continued effort to bolster national preparedness against emerging biological threats, the Biomedical Advanced Research and Development Authority (BARDA) has released the Phase 2 issue of the “Biothreat Diagnostic Rapid Response” Solicitation (RPP-25-06-DxR2) on May 29, 2025, under its Rapid Response Partnership Vehicle (RRPV). BARDA is seeking to address pressing gaps in diagnostic test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness Read More »

radiation voltaics

Rads to Watts Proposers Day

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Program Overview Rads to Watts is a DARPA program dedicated to pioneering innovative methods for directly converting nuclear radiation into electricity, with a primary emphasis on radiation voltaics (also known as radiovoltaics). The program’s long-term goal is to develop radiovoltaic systems capable of transforming high-power nuclear radiation into kilowatts of electrical energy. Achieving operation at

Rads to Watts Proposers Day Read More »

Two scientists in lab coats at a computer discussing their findings

DARPA’s RFI on Advanced Disease Outbreak Simulation

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Advanced Disease Outbreaks Simulation Capabilities The Defense Advanced Research Projects Agency (DARPA) has issued a new Request for Information (RFI) titled “Advanced Disease Outbreaks Simulation Capabilities” (DARPA-SN-25-72). This announcement seeks insights from the research and development community on cutting-edge outbreak modeling tools to increase understanding of outbreak dynamics and improve future public health emergency preparedness.

DARPA’s RFI on Advanced Disease Outbreak Simulation Read More »

Pentagon Department of Defense

DPA Title III RFI on Advanced Canopy Transparencies

Leave a Comment / DPA, Emerging Technologies / By

Defense Production Act (DPA) Title III Request for Information (RFI) on Advanced Canopy Transparencies In an effort to fortify the defense industrial base and enhance the reliability of critical aviation components, the U.S. Air Force Research Laboratory (AFRL) has issued a Request for Information (RFI) under Title III of the Defense Production Act (DPA). This

DPA Title III RFI on Advanced Canopy Transparencies Read More »

Conveyor belt with blue capsules medicine

ASPR RFI: Public Health Industrial Base Capabilities and Capacities: Essential Medicines

Leave a Comment / ASPR-IBx, Life Sciences / By

ASPR Industrial Base Management and Supply Chain Request for Information (RFI) Understanding the RFI The Public Health Industrial Base Capabilities and Capacities: Essential Medicines RFI is seeking detailed input from domestic manufacturers and industry stakeholders to better understand the current capabilities and constraints in producing a list of 28 designated essential medicines. The scope includes

ASPR RFI: Public Health Industrial Base Capabilities and Capacities: Essential Medicines Read More »

Scroll to Top